{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T02:48:33Z","timestamp":1767840513818,"version":"3.49.0"},"reference-count":90,"publisher":"The Microbiological Society of Korea","issue":"3","license":[{"start":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T00:00:00Z","timestamp":1643328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T00:00:00Z","timestamp":1643328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Microbiol."],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s12275-022-1547-8","type":"journal-article","created":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T09:02:41Z","timestamp":1643360561000},"page":"238-246","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Middle East Respiratory Syndrome coronavirus vaccine development: updating clinical studies using platform technologies"],"prefix":"10.71150","volume":"60","author":[{"given":"Jung-ah","family":"Choi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae-Ouk","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4586","published-online":{"date-parts":[[2022,1,28]]},"reference":[{"key":"1547_CR1","doi-asserted-by":"crossref","first-page":"e00027","DOI":"10.1128\/JVI.00027-18","volume":"92","author":"S Agnihothram","year":"2018","unstructured":"Agnihothram, S., Menachery, V.D., Yount, B.L. Jr., Lindesmith, L.C., Scobey, T., Whitmore, A., Sch\u00e4fer, A., Heise, M.T., and Baric, R.S. 2018. Development of a broadly accessible venezuelan equine encephalitis virus replicon particle vaccine platform. J. Virol. 92, e00027\u201318.","journal-title":"J. Virol."},{"key":"1547_CR2","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1080\/21645515.2016.1177688","volume":"12","author":"AS Agrawal","year":"2016","unstructured":"Agrawal, A.S., Tao, X., Algaissi, A., Garron, T., Narayanan, K., Peng, B.H., Couch, R.B., and Tseng, C.T. 2016. Immunization with inactivated middle east respiratory syndrome coronavirus vaccine leads to lung immunopathology on challenge with live virus. Hum. Vaccin Immunother. 12, 2351\u20132356.","journal-title":"Hum. Vaccin Immunother."},{"key":"1547_CR3","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/nbt0998-867","volume":"16","author":"H Aihara","year":"1998","unstructured":"Aihara, H. and Miyazaki, J. 1998. Gene transfer into muscle by electroporation in vivo. Nat. Biotechnol. 16, 867\u2013870.","journal-title":"Nat. Biotechnol."},{"key":"1547_CR4","doi-asserted-by":"crossref","first-page":"44875","DOI":"10.1038\/srep44875","volume":"7","author":"SS Al-Amri","year":"2017","unstructured":"Al-Amri, S.S., Abbas, A.T., Siddiq, L.A., Alghamdi, A., Sanki, M.A., Al-Muhanna, M.K., Alhabbab, R.Y., Azhar, E.I., Li, X., and Hashem, A.M. 2017. Immunogenicity of candidate MERS-CoV DNA vaccines based on the spike protein. Sci. Rep. 7, 44875.","journal-title":"Sci. Rep."},{"key":"1547_CR5","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1016\/j.vaccine.2017.05.032","volume":"35","author":"NK Alharbi","year":"2017","unstructured":"Alharbi, N.K., Padron-Regalado, E., Thompson, C.P., Kupke, A., Wells, D., Sloan, M.A., Grehan, K., Temperton, N., Lambe, T., Warimwe, G., et al. 2017. ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in mice. Vaccine 35, 3780\u20133788.","journal-title":"Vaccine"},{"key":"1547_CR6","doi-asserted-by":"crossref","first-page":"16292","DOI":"10.1038\/s41598-019-52730-4","volume":"9","author":"NK Alharbi","year":"2019","unstructured":"Alharbi, N.K., Qasim, I., Almasoud, A., Aljami, H.A., Alenazi, M.W., Alhafufi, A., Aldibasi, O.S., Hashem, A.M., Kasem, S., Albrahim, R., et al. 2019. Humoral immunogenicity and efficacy of a single dose of chadox1 mers vaccine candidate in dromedary camels. Sci. Rep. 9, 16292.","journal-title":"Sci. Rep."},{"key":"1547_CR7","doi-asserted-by":"crossref","first-page":"e00650","DOI":"10.1128\/mBio.00650-13","volume":"4","author":"F Almaz\u00e1n","year":"2013","unstructured":"Almaz\u00e1n, F., DeDiego, M.L., Sola, I., Zu\u00f1iga, S., Nieto-Torres, J.L., Marquez-Jurado, S., Andr\u00e9s, G., and Enjuanes, L. 2013. Engineering a replication-competent, propagation-defective Middle East Respiratory Syndrome coronavirus as a vaccine candidate. mBio 4, e00650\u201313.","journal-title":"mBio"},{"key":"1547_CR8","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00103-019-03061-2","volume":"63","author":"V Bernasconi","year":"2020","unstructured":"Bernasconi, V., Kristiansen, P.A., Whelan, M., Rom\u00e1n, R.G., Bettis, A., Yimer, S.A., Gurry, C., Andersen, S.R., Yeskey, D., Mandi, H., et al. 2020. Developing vaccines against epidemic-prone emerging infectious diseases. Bundesgesundheitsbl. 63, 65\u201373.","journal-title":"Bundesgesundheitsbl"},{"key":"1547_CR9","doi-asserted-by":"crossref","first-page":"107493","DOI":"10.1016\/j.intimp.2021.107493","volume":"95","author":"EA Bhat","year":"2021","unstructured":"Bhat, E.A., Khan, J., Sajjad, N., Ali, A., Aldakeel, F.M., Mateen, A., Alqahtani, M.S., and Syed, R. 2021. SARS-CoV-2: Insight in genome structure, pathogenesis and viral receptor binding analysis \u2014 an updated review. Int. Immunopharmacol. 95, 107493.","journal-title":"Int. Immunopharmacol."},{"key":"1547_CR10","doi-asserted-by":"crossref","first-page":"12201","DOI":"10.1128\/JVI.06048-11","volume":"85","author":"M Bolles","year":"2011","unstructured":"Bolles, M., Deming, D., Long, K., Agnihothram, S., Whitmore, A., Ferris, M., Funkhouser, W., Gralinski, L., Totura, A., Heise, M., et al. 2011. A double-inactivated severe acute respiratory syndrome coronavirus vaccine provides incomplete protection in mice and induces increased eosinophilic proinflammatory pulmonary response upon challenge. J. Virol. 85, 12201\u201312215.","journal-title":"J. Virol."},{"key":"1547_CR11","doi-asserted-by":"crossref","first-page":"8801","DOI":"10.1128\/JVI.77.16.8801-8811.2003","volume":"77","author":"BJ Bosch","year":"2003","unstructured":"Bosch, B.J., van der Zee, R., de Haan, C.A., and Rottier, P.J.M. 2003. The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex. J. Virol. 77, 8801\u20138811.","journal-title":"J. Virol."},{"key":"1547_CR12","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0092-8674(00)80205-6","volume":"89","author":"DC Chan","year":"1997","unstructured":"Chan, D.C., Fass, D., Berger, J.M., and Kim, P.S. 1997. Core structure of gp41 from the HIV envelope glycoprotein. Cell 89, 263\u2013273.","journal-title":"Cell"},{"key":"1547_CR13","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/S1473-3099(21)00200-0","volume":"21","author":"KJ Chappell","year":"2021","unstructured":"Chappell, K.J., Mordant, F.L., Li, Z., Wijesundara, D.K., Ellenberg, P., Lackenby, J.A., Cheung, S.T.M., Modhiran, N., Avumegah, M.S., Henderson, C.L., et al. 2021. Safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2: a randomised, double-blind, placebo-controlled, phase 1 trial. Lancet Infect. Dis. 21, 1383\u20131394.","journal-title":"Lancet Infect. Dis."},{"key":"1547_CR14","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/jmv.25681","volume":"92","author":"Y Chen","year":"2020","unstructured":"Chen, Y., Liu, Q., and Guo, D. 2020. Emerging coronaviruses: genome structure, replication, and pathogenesis. J. Med. Virol. 92, 418\u2013423.","journal-title":"J. Med. Virol."},{"key":"1547_CR15","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1038\/sj.gt.3300994","volume":"6","author":"N Chirmule","year":"1999","unstructured":"Chirmule, N., Propert, K., Magosin, S., Qian, Y., Qian, R., and Wilson, J. 1999. Immune responses to adenovirus and adeno-associated virus in humans. Gene Ther. 6, 1574\u20131583.","journal-title":"Gene Ther."},{"key":"1547_CR16","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/S0140-6736(16)30623-7","volume":"388","author":"SY Cho","year":"2016","unstructured":"Cho, S.Y., Kang, J.M., Ha, Y.E., Park, G.E., Lee, J.Y., Ko, J.H., Kim, J.M., Kang, C.I., Jo, I.J., Ryu, J.G., et al. 2016. MERS-CoV outbreak following a single patient exposure in an emergency room in South Korea: an epidemiological outbreak study. Lancet 388, 994\u20131001.","journal-title":"Lancet"},{"key":"1547_CR17","first-page":"e01176","volume":"94","author":"JA Choi","year":"2020","unstructured":"Choi, J.A., Goo, J., Yang, E., Jung, D.I., Lee, S., Rho, S., Jeong, Y., Park, Y.S., Park, H., Moon, Y.H., et al. 2020. Cross-protection against MERS-CoV by prime-boost vaccination using viral spike DNA and protein. J. Virol. 94, e01176\u201320.","journal-title":"J. Virol."},{"key":"1547_CR18","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1016\/j.vaccine.2014.04.016","volume":"32","author":"CM Coleman","year":"2014","unstructured":"Coleman, C.M., Liu, Y.V., Mu, H., Taylor, J.K., Massare, M., Flyer, D.C., Smith, G.E., and Frieman, M.B. 2014. Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice. Vaccine 32, 3169\u20133174.","journal-title":"Vaccine"},{"key":"1547_CR19","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.vaccine.2017.02.012","volume":"35","author":"CM Coleman","year":"2017","unstructured":"Coleman, C.M., Venkataraman, T., Liu, Y.V., Glenn, G.M., Smith, G.E., Flyer, D.C., and Frieman, M.B. 2017. MERS-CoV spike nanoparticles protect mice from MERS-CoV infection. Vaccine 35, 1586\u20131589.","journal-title":"Vaccine"},{"key":"1547_CR20","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41577-020-00480-0","volume":"21","author":"L Dai","year":"2021","unstructured":"Dai, L. and Gao, G.F. 2021. Viral targets for vaccines against COVID-19. Nat. Rev. Immunol. 21, 73\u201382.","journal-title":"Nat. Rev. Immunol."},{"key":"1547_CR21","doi-asserted-by":"crossref","first-page":"7790","DOI":"10.1128\/JVI.01244-13","volume":"87","author":"RJ de Groot","year":"2013","unstructured":"de Groot, R.J., Baker, S.C., Baric, R.S., Brown, C.S., Drosten, C., Enjuanes, L., Fouchier, R.A.M., Galiano, M., Gorbalenya, A.E., Memish, Z.A., et al. 2013. Middle East respiratory syndrome coronavirus (MERS-CoV): Announcement of the coronavirus study group. J. Virol. 87, 7790\u20137792.","journal-title":"J. Virol."},{"key":"1547_CR22","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41426-018-0056-7","volume":"7","author":"Y Deng","year":"2018","unstructured":"Deng, Y., Lan, J., Bao, L., Huang, B., Ye, F., Chen, Y., Yao, Y., Wang, W., Qin, C., and Tan, W. 2018. Enhanced protection in mice induced by immunization with inactivated whole viruses compare to spike protein of middle east respiratory syndrome coronavirus. Emerg. Microbes Infect. 7, 60.","journal-title":"Emerg. Microbes Infect."},{"key":"1547_CR23","doi-asserted-by":"crossref","first-page":"114","DOI":"10.32607\/actanaturae.11042","volume":"12","author":"IV Dolzhikova","year":"2020","unstructured":"Dolzhikova, I.V., Grousova, D.M., Zubkova, O.V., Tukhvatulin, A.I., Kovyrshina, A.V., Lubenets, N.L., Ozharovskaia, T.A., Popova, O., Esmagambetov, I.B., Shcheblyakov, D.V., et al. 2020. Preclinical studies of immunogenity, protectivity, and safety of the combined vector vaccine for prevention of the Middle East respiratory syndrome. Acta Naturae 12, 114\u2013123.","journal-title":"Acta Naturae"},{"key":"1547_CR24","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1056\/NEJMoa1405858","volume":"371","author":"C Drosten","year":"2014","unstructured":"Drosten, C., Meyer, B., M\u00fcller, M.A., Corman, V.M., Al-Masri, M., Hossain, R., Madani, H., Sieberg, A., Bosch, B.J., Lattwein, E., et al. 2014. Transmission of MERS-coronavirus in household contacts. N. Engl. J. Med. 371, 828\u2013835.","journal-title":"N. Engl. J. Med."},{"key":"1547_CR25","doi-asserted-by":"crossref","first-page":"9939","DOI":"10.1128\/JVI.01048-13","volume":"87","author":"L Du","year":"2013","unstructured":"Du, L., Zhao, G., Kou, Z., Ma, C., Sun, S., Poon, V.K.M., Lu, L., Wang, L., Debnath, A.K., Zheng, B.J., et al. 2013. Identification of a receptor-binding domain in the s protein of the novel human coronavirus middle east respiratory syndrome coronavirus as an essential target for vaccine development. J. Virol. 87, 9939\u20139942.","journal-title":"J. Virol."},{"key":"1547_CR26","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.virusres.2007.01.021","volume":"133","author":"L Enjuanes","year":"2008","unstructured":"Enjuanes, L., Dediego, M.L., Alvarez, E., Deming, D., Sheahan, T., and Baric, R. 2008. Vaccines to prevent severe acute respiratory syndrome coronavirus-induced disease. Virus Res. 133, 45\u201362.","journal-title":"Virus Res."},{"key":"1547_CR27","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1046\/j.1365-2893.1998.00106.x","volume":"5","author":"CP Eyigun","year":"1998","unstructured":"Eyigun, C.P., Yilmaz, S., G\u00fcl, C., Seng\u00fcl, A., Hacibektasoglu, A., and Van Thiel, D.H. 1998. A comparative trial of two surface subunit recombinant hepatitis B vaccines vs a surface and pres sub-unit vaccine for immunization of healthy adults. J. Viral Hepat. 5, 265\u2013269.","journal-title":"J. Viral Hepat."},{"key":"1547_CR28","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S1473-3099(20)30160-2","volume":"20","author":"PM Folegatti","year":"2020","unstructured":"Folegatti, P.M., Bittaye, M., Flaxman, A., Lopez, F.R., Bellamy, D., Kupke, A., Mair, C., Makinson, R., Sheridan, J., Rohde, C., et al. 2020. Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial. Lancet Infect. Dis. 20, 816\u2013826.","journal-title":"Lancet Infect. Dis."},{"key":"1547_CR29","doi-asserted-by":"crossref","first-page":"197863","DOI":"10.1016\/j.virusres.2020.197863","volume":"278","author":"J Goo","year":"2020","unstructured":"Goo, J., Jeong, Y., Park, Y.S., Yang, E., Jung, D.I., Rho, S., Park, U., Sung, H., Park, P.G., Choi, J.A., et al. 2020. Characterization of novel monoclonal antibodies against MERS-coronavirus spike protein. Virus Res. 278, 197863.","journal-title":"Virus Res."},{"key":"1547_CR30","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/epirev\/mxz012","volume":"41","author":"D Gouglas","year":"2019","unstructured":"Gouglas, D., Christodoulou, M., Plotkin, S.A., and Hatchett, R. 2019. CEPI: Driving progress toward epidemic preparedness and response. Epidemiol. Rev. 41, 28\u201333.","journal-title":"Epidemiol. Rev."},{"key":"1547_CR31","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/nrmicro3143","volume":"11","author":"RL Graham","year":"2013","unstructured":"Graham, R.L., Donaldson, E.F., and Baric, R.S. 2013. A decade after SARS: strategies for controlling emerging coronaviruses. Nat. Rev. Microbiol. 11, 836\u2013848.","journal-title":"Nat. Rev. Microbiol."},{"key":"1547_CR32","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/imm.12462","volume":"145","author":"X Guo","year":"2015","unstructured":"Guo, X., Deng, Y., Chen, H., Lan, J., Wang, W., Zou, X., Hung, T., Lu, Z., and Tan, W. 2015. Systemic and mucosal immunity in mice elicited by a single immunization with human adenovirus type 5 or 41 vector-based vaccines carrying the spike protein of Middle East respiratory syndrome coronavirus. Immunology 145, 476\u2013484.","journal-title":"Immunology"},{"key":"1547_CR33","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1126\/science.aad1283","volume":"351","author":"BL Haagmans","year":"2016","unstructured":"Haagmans, B.L., van den Brand, J.M.A., Raj, V.S., Volz, A., Wohlsein, P., Smits, S.L., Schipper, D., Bestebroer, T.M., Okba, N., Fux, R., et al. 2016. An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels. Science 351, 77\u201381.","journal-title":"Science"},{"key":"1547_CR34","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1056\/NEJMoa1310566","volume":"369","author":"SM Hammer","year":"2013","unstructured":"Hammer, S.M., Sobieszczyk, M.E., Janes, H., Karuna, S.T., Mulligan, M.J., Grove, D., Koblin, B.A., Buchbinder, S.P., Keefer, M.C., Tomaras, G.D., et al. 2013. Efficacy trial of a DNA\/rAd5 HIV-1 preventive vaccine. N. Engl. J. Med. 369, 2083\u20132092.","journal-title":"N. Engl. J. Med."},{"key":"1547_CR35","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1042\/BA20000034","volume":"32","author":"M Hansson","year":"2000","unstructured":"Hansson, M., Nygren, P.A., and St\u00e5hl, S. 2000. Design and production of recombinant subunit vaccines. Biotechnol. Appl. Biochem. 32, 95\u2013107.","journal-title":"Biotechnol. Appl. Biochem."},{"key":"1547_CR36","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/tbed.12401","volume":"64","author":"MG Hemida","year":"2017","unstructured":"Hemida, M.G., Elmoslemany, A., Al-Hizab, F., Alnaeem, A., Almathen, F., Faye, B., Chu, D.K.W., Perera, R.A.P.M., and Peiris, M. 2017. Dromedary camels and the transmission of Middle East respiratory syndrome coronavirus (MERS-CoV). Transbound. Emerg. Dis. 64, 344\u2013353.","journal-title":"Transbound. Emerg. Dis."},{"key":"1547_CR37","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1073\/pnas.1809667116","volume":"116","author":"RJG Hulswit","year":"2019","unstructured":"Hulswit, R.J.G., Lang, Y., Bakkers, M.J.G., Li, W., Li, Z., Schouten, A., Ophorst, B., van Kuppeveld, F.J.M., Boons, G.J., Bosch, B.J., et al. 2019. Human coronaviruses OC43 and HKU1 bind to 9-O-acetylated sialic acids via a conserved receptor-binding site in spike protein domain A. Proc. Natl. Acad. Sci. USA 116, 2681\u20132690.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1547_CR38","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3390\/vaccines9020071","volume":"9","author":"A Isaacs","year":"2021","unstructured":"Isaacs, A., Li, Z., Cheung, S.T.M., Wijesundara, D.K., McMillan, C.L.D., Modhiran, N., Young, P.R., Ranasinghe, C., Watterson, D., and Chappell, K.J. 2021. Adjuvant selection for influenza and RSV prefusion subunit vaccines. Vaccines 9, 71.","journal-title":"Vaccines"},{"key":"1547_CR39","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.vaccine.2016.11.064","volume":"35","author":"L Jiaming","year":"2017","unstructured":"Jiaming, L., Yanfeng, Y., Yao, D., Yawei, H., Linlin, B., Baoying, H., Jinghua, Y., Gao, G.F., Chuan, Q., and Wenjie, T. 2017. The recombinant n-terminal domain of spike proteins is a potential vaccine against Middle East respiratory syndrome coronavirus (MERS-CoV) infection. Vaccine 35, 10\u201318.","journal-title":"Vaccine"},{"key":"1547_CR40","doi-asserted-by":"crossref","first-page":"3468","DOI":"10.1016\/j.vaccine.2018.04.082","volume":"36","author":"SY Jung","year":"2018","unstructured":"Jung, S.Y., Kang, K.W., Lee, E.Y., Seo, D.W., Kim, H.L., Kim, H., Kwon, T., Park, H.L., Kim, H., Lee, S. M., et al. 2018. Heterologous prime-boost vaccination with adenoviral vector and protein nanoparticles induces both Th1 and Th2 responses against middle east respiratory syndrome coronavirus. Vaccine 36, 3468\u20133476.","journal-title":"Vaccine"},{"key":"1547_CR41","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s13577-021-00512-4","volume":"34","author":"S Kashte","year":"2021","unstructured":"Kashte, S., Gulbake, A., El-Amin Iii, S.F., and Gupta, A. 2021. COVID-19 vaccines: rapid development, implications, challenges and future prospects. Hum. Cell 34, 711\u2013733.","journal-title":"Hum. Cell"},{"key":"1547_CR42","doi-asserted-by":"crossref","first-page":"599","DOI":"10.4161\/hv.23241","volume":"9","author":"MC Knuchel","year":"2013","unstructured":"Knuchel, M.C., Marty, R.R., Morin, T.N., Ilter, O., Zuniga, A., and Naim, H.Y. 2013. Relevance of a pre-existing measles immunity prior immunization with a recombinant measles virus vector. Hum. Vaccin. Immunother. 9, 599\u2013606.","journal-title":"Hum. Vaccin. Immunother."},{"key":"1547_CR43","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S1473-3099(20)30248-6","volume":"20","author":"T Koch","year":"2020","unstructured":"Koch, T., Dahlke, C., Fathi, A., Kupke, A., Kr\u00e4hling, V., Okba, N.M.A., Halwe, S., Rohde, C., Eickmann, M., Volz, A., et al. 2020. Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trial. Lancet Infect. Dis. 20, 827\u2013838.","journal-title":"Lancet Infect. Dis."},{"key":"1547_CR44","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.biologicals.2018.05.004","volume":"54","author":"MC Langenmayer","year":"2018","unstructured":"Langenmayer, M.C., L\u00fclf-Averhoff, A.T., Adam-Neumair, S., Fux, R., Sutter, G., and Volz, A. 2018. Distribution and absence of generalized lesions in mice following single dose intramuscular inoculation of the vaccine candidate MVA-MERS-S. Biologicals 54, 58\u201362.","journal-title":"Biologicals"},{"key":"1547_CR45","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12929-020-00695-2","volume":"27","author":"YD Li","year":"2020","unstructured":"Li, Y.D., Chi, W.Y., Su, J.H., Ferrall, L., Hung, C.F., and Wu, T.C. 2020. Coronavirus vaccine development: from SARS and MERS to COVID-19. J. Biomed. Sci. 27, 104.","journal-title":"J. Biomed. Sci."},{"key":"1547_CR46","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1600-065X.2010.00980.x","volume":"239","author":"MA Liu","year":"2011","unstructured":"Liu, M.A. 2011. DNA vaccines: an historical perspective and view to the future. Immunol. Rev. 239, 62\u201384.","journal-title":"Immunol. Rev."},{"key":"1547_CR47","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1016\/S2095-3119(17)61660-5","volume":"16","author":"RQ Liu","year":"2017","unstructured":"Liu, R.Q., Ge, J.Y., Wang, J.L., Shao, Y., Zhang, H.L., Wang, J.L., Wen, Z.Y., and Bu, Z.G. 2017. Newcastle disease virus-based MERS-CoV candidate vaccine elicits high-level and lasting neutralizing antibodies in bactrian camels. J Integr Agric. 16, 2264\u20132273.","journal-title":"J Integr Agric."},{"key":"1547_CR48","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.antiviral.2017.12.007","volume":"150","author":"R Liu","year":"2018","unstructured":"Liu, R., Wang, J., Shao, Y., Wang, X., Zhang, H., Shuai, L., Ge, J., Wen, Z., and Bu, Z. 2018. A recombinant VSV-vectored MERS-CoV vaccine induces neutralizing antibody and T cell responses in rhesus monkeys after single dose immunization. Antiviral Res. 150, 30\u201338.","journal-title":"Antiviral Res."},{"key":"1547_CR49","doi-asserted-by":"crossref","first-page":"11654","DOI":"10.1128\/JVI.01815-15","volume":"89","author":"AH Malczyk","year":"2015","unstructured":"Malczyk, A.H., Kupke, A., Pr\u00fcfer, S., Scheuplein, V.A., Hutzler, S., Kreuz, D., Beissert, T., Bauer, S., Hubich-Rau, S., Tondera, C., et al. 2015. A highly immunogenic and protective Middle East respiratory syndrome coronavirus vaccine based on a recombinant measles virus vaccine platform. J. Virol. 89, 11654\u201311667.","journal-title":"J. Virol."},{"key":"1547_CR50","doi-asserted-by":"crossref","first-page":"e1266","DOI":"10.1016\/S2214-109X(18)30418-2","volume":"6","author":"JN Maslow","year":"2018","unstructured":"Maslow, J.N. 2018. The cost and challenge of vaccine development for emerging and emergent infectious diseases. Lancet Glob. Health 6, e1266\u2013e1267.","journal-title":"Lancet Glob. Health"},{"key":"1547_CR51","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.vaccine.2009.10.145","volume":"28","author":"TC Mast","year":"2010","unstructured":"Mast, T.C., Kierstead, L., Gupta, S.B., Nikas, A.A., Kallas, E.G., Novitsky, V., Mbewe, B., Pitisuttithum, P., Schechter, M., Vardas, E., et al. 2010. International epidemiology of human pre-existing adenovirus (Ad) type-5, type-6, type-26 and type-36 neutralizing antibodies: correlates of high Ad5 titers and implications for potential HIV vaccine trials. Vaccine 28, 950\u2013957.","journal-title":"Vaccine"},{"key":"1547_CR52","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1126\/science.1243283","volume":"342","author":"JS McLellan","year":"2013","unstructured":"McLellan, J.S., Chen, M., Joyce, M.G., Sastry, M., Stewart-Jones, G.B.E., Yang, Y., Zhang, B., Chen, L., Srivatsan, S., Zheng, A., et al. 2013. Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus. Science 342, 592\u2013598.","journal-title":"Science"},{"key":"1547_CR53","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.antiviral.2018.09.009","volume":"159","author":"MS Mehand","year":"2018","unstructured":"Mehand, M.S., Al-Shorbaji, F., Millett, P., and Murgue, B. 2018. The WHO R&D Blueprint: 2018 review of emerging infectious diseases requiring urgent research and development efforts. Antiviral Res. 159, 63\u201367.","journal-title":"Antiviral Res."},{"key":"1547_CR54","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S0140-6736(19)33221-0","volume":"395","author":"ZA Memish","year":"2020","unstructured":"Memish, Z.A., Perlman, S., Van Kerkhove, M.D., and Zumla, A. 2020. Middle East respiratory syndrome. Lancet 395, 1063\u20131077.","journal-title":"Lancet"},{"key":"1547_CR55","doi-asserted-by":"crossref","first-page":"6188","DOI":"10.1073\/pnas.0400542101","volume":"101","author":"GT Mercier","year":"2004","unstructured":"Mercier, G.T., Campbell, J.A., Chappell, J.D., Stehle, T., Dermody, T.S., and Barry, M.A. 2004. A chimeric adenovirus vector encoding reovirus attachment protein sigma1 targets cells expressing junctional adhesion molecule 1. Proc. Natl. Acad. Sci. USA 101, 6188\u20136193.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1547_CR56","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.virol.2015.03.032","volume":"479\u2013480","author":"PD Minor","year":"2015","unstructured":"Minor, P.D. 2015. Live attenuated vaccines: historical successes and current challenges. Virology 479\u2013480, 379\u2013392.","journal-title":"Virology"},{"key":"1547_CR57","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.vaccine.2016.03.104","volume":"34","author":"K Modjarrad","year":"2016","unstructured":"Modjarrad, K. 2016. MERS-CoV vaccine candidates in development: the current landscape. Vaccine 34, 2982\u20132987.","journal-title":"Vaccine"},{"key":"1547_CR58","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S1473-3099(19)30266-X","volume":"19","author":"K Modjarrad","year":"2019","unstructured":"Modjarrad, K., Roberts, C.C., Mills, K.T., Castellano, A.R., Paolino, K., Muthumani, K., Reuschel, E.L., Robb, M.L., Racine, T., Oh, M.D., et al. 2019. Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial. Lancet Infect. Dis. 19, 1013\u20131022.","journal-title":"Lancet Infect. Dis."},{"key":"1547_CR59","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12985-016-0544-0","volume":"13","author":"HA Mohd","year":"2016","unstructured":"Mohd, H.A., Al-Tawfiq, J.A., and Memish, Z.A. 2016. Middle east respiratory syndrome coronavirus (MERS-CoV) origin and animal reservoir. Virol. J. 13, 87.","journal-title":"Virol. J."},{"key":"1547_CR60","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41541-017-0029-1","volume":"2","author":"VJ Munster","year":"2017","unstructured":"Munster, V.J., Wells, D., Lambe, T., Wright, D., Fischer, R.J., Bushmaker, T., Saturday, G., van Doremalen, N., Gilbert, S.C., de Wit, E., et al. 2017. Protective efficacy of a novel simian adenovirus vaccine against lethal MERS-CoV challenge in a transgenic human DPP4 mouse model. npj Vaccines 2, 28.","journal-title":"npj Vaccines"},{"key":"1547_CR61","doi-asserted-by":"crossref","first-page":"301ra132","DOI":"10.1126\/scitranslmed.aac7462","volume":"7","author":"K Muthumani","year":"2015","unstructured":"Muthumani, K., Falzarano, D., Reuschel, E.L., Tingey, C., Flingai, S., Villarreal, D.O., Wise, M., Patel, A., Izmirly, A., Aljuaid, A., et al. 2015. A synthetic consensus anti-spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates. Sci. Transl. Med. 7, 301ra132.","journal-title":"Sci. Transl. Med."},{"key":"1547_CR62","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1749-6632.1995.tb44729.x","volume":"772","author":"WW Nichols","year":"1995","unstructured":"Nichols, W.W., Ledwith, B.J., Manam, S.V., and Troilo, P.J. 1995. Potential DNA vaccine integration into host cell genome. Ann. N. Y. Acad. Sci. 772, 30\u201339.","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"1547_CR63","doi-asserted-by":"crossref","first-page":"E7348","DOI":"10.1073\/pnas.1707304114","volume":"114","author":"J Pallesen","year":"2017","unstructured":"Pallesen, J., Wang, N., Corbett, K.S., Wrapp, D., Kirchdoerfer, R.N., Turner, H.L., Cottrell, C.A., Becker, M.M., Wang, L., Shi, W., et al. 2017. Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen. Proc. Natl. Acad. Sci. USA 114, E7348\u2013E7357.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1547_CR64","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nature13808","volume":"514","author":"M Pancera","year":"2014","unstructured":"Pancera, M., Zhou, T., Druz, A., Georgiev, I.S., Soto, C., Gorman, J., Huang, J., Acharya, P., Chuang, G.Y., Ofek, G., et al. 2014. Structure and immune recognition of trimeric pre-fusion HIV-1 Env. Nature 514, 455\u2013461.","journal-title":"Nature"},{"key":"1547_CR65","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1080\/21645515.2017.1306615","volume":"13","author":"SA Plotkin","year":"2017","unstructured":"Plotkin, S.A. 2017. Vaccines for epidemic infections and the role of CEPI. Hum. Vaccin. Immunother. 13, 2755\u20132762.","journal-title":"Hum. Vaccin. Immunother."},{"key":"1547_CR66","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.3389\/fimmu.2018.01963","volume":"9","author":"S Rauch","year":"2018","unstructured":"Rauch, S., Jasny, E., Schmidt, K.E., and Petsch, B. 2018. New vaccine technologies to combat outbreak situations. Front. Immunol. 9, 1963.","journal-title":"Front. Immunol."},{"key":"1547_CR67","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.coi.2011.03.006","volume":"23","author":"CS Rollier","year":"2011","unstructured":"Rollier, C.S., Reyes-Sandoval, A., Cottingham, M.G., Ewer, K., and Hill, A.V. 2011. Viral vectors as vaccine platforms: deployment in sight. Curr. Opin. Immunol. 23, 377\u2013382.","journal-title":"Curr. Opin. Immunol."},{"key":"1547_CR68","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1056\/NEJMp1613577","volume":"376","author":"JA R\u00f8ttingen","year":"2017","unstructured":"R\u00f8ttingen, J.A., Gouglas, D., Feinberg, M., Plotkin, S., Raghavan, K.V., Witty, A., Draghia-Akli, R., Stoffels, P., and Piot, P. 2017. New vaccines against epidemic infectious diseases. N. Engl. J. Med. 376, 610\u2013613.","journal-title":"N. Engl. J. Med."},{"key":"1547_CR69","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.coi.2011.03.008","volume":"23","author":"NY Sardesai","year":"2011","unstructured":"Sardesai, N.Y. and Weiner, D.B. 2011. Electroporation delivery of DNA vaccines: prospects for success. Curr. Opin. Immunol. 23, 421\u2013429.","journal-title":"Curr. Opin. Immunol."},{"key":"1547_CR70","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3390\/v11010074","volume":"11","author":"C Schindewolf","year":"2019","unstructured":"Schindewolf, C. and Menachery, V.D. 2019. Middle East respiratory syndrome vaccine candidates: cautious optimism. Viruses 11, 74.","journal-title":"Viruses"},{"key":"1547_CR71","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1093\/toxsci\/kfj169","volume":"91","author":"RL Sheets","year":"2006","unstructured":"Sheets, R.L., Stein, J., Manetz, T.S., Duffy, C., Nason, M., Andrews, C., Kong, W.P., Nabel, G.J., and Gomez, P.L. 2006. Biodistribution of DNA plasmid vaccines against HIV-1, Ebola, severe acute respiratory syndrome, or west nile virus is similar, without integration, despite differing plasmid backbones or gene inserts. Toxicol. Sci. 91, 610\u2013619.","journal-title":"Toxicol. Sci."},{"key":"1547_CR72","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1038\/s41467-020-16505-0","volume":"11","author":"TRF Smith","year":"2020","unstructured":"Smith, T.R.F., Patel, A., Ramos, S., Elwood, D., Zhu, X., Yan, J., Gary, E.N., Walker, S.N., Schultheis, K., Purwar, M., et al. 2020. Immunogenicity of a DNA vaccine candidate for COVID-19. Nat. Commun. 11, 2601.","journal-title":"Nat. Commun."},{"key":"1547_CR73","doi-asserted-by":"crossref","first-page":"11950","DOI":"10.1128\/JVI.01672-13","volume":"87","author":"F Song","year":"2013","unstructured":"Song, F., Fux, R., Provacia, L.B., Volz, A., Eickmann, M., Becker, S., Osterhaus, A.D., Haagmans, B.L., and Sutter, G. 2013. Middle East respiratory syndrome coronavirus spike protein delivered by modified vaccinia virus Ankara efficiently induces virus-neutralizing antibodies. J. Virol. 87, 11950\u201311954.","journal-title":"J. Virol."},{"key":"1547_CR74","doi-asserted-by":"crossref","first-page":"3700","DOI":"10.1016\/S0264-410X(01)00075-5","volume":"19","author":"KJ Stittelaar","year":"2001","unstructured":"Stittelaar, K.J., Kuiken, T., de Swart, R.L., van Amerongen, G., Vos, H.W., Niesters, H.G., van Schalkwijk, P., van der Kwast, T., Wyatt, L.S., Moss, B., et al. 2001. Safety of modified vaccinia virus Ankara (MVA) in immune-suppressed macaques. Vaccine 19, 3700\u20133709.","journal-title":"Vaccine"},{"key":"1547_CR75","doi-asserted-by":"crossref","first-page":"10847","DOI":"10.1073\/pnas.89.22.10847","volume":"89","author":"G Sutter","year":"1992","unstructured":"Sutter, G. and Moss, B. 1992. Nonreplicating vaccinia vector efficiently expresses recombinant genes. Proc. Natl. Acad. Sci. USA 89, 10847\u201310851.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1547_CR76","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.virol.2016.10.005","volume":"499","author":"W Tai","year":"2016","unstructured":"Tai, W., Zhao, G., Sun, S., Guo, Y., Wang, Y., Tao, X., Tseng, C.T.K., Li, F., Jiang, S., Du, L., et al. 2016. A recombinant receptor-binding domain of MERS-CoV in trimeric form protects human dipeptidyl peptidase 4 (hDPP4) transgenic mice from MERS-CoV infection. Virology 499, 375\u2013382.","journal-title":"Virology"},{"key":"1547_CR77","doi-asserted-by":"crossref","first-page":"e35421","DOI":"10.1371\/journal.pone.0035421","volume":"7","author":"CT Tseng","year":"2012","unstructured":"Tseng, C.T., Sbrana, E., Iwata-Yoshikawa, N., Newman, P.C., Garron, T., Atmar, R.L., Peters, C.J., and Couch, R.B. 2012. Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus. PLoS ONE 7, e35421.","journal-title":"PLoS ONE"},{"key":"1547_CR78","doi-asserted-by":"crossref","first-page":"e00473","DOI":"10.1128\/mBio.00473-12","volume":"3","author":"S van Boheemen","year":"2012","unstructured":"van Boheemen, S., de Graaf, M., Lauber, C., Bestebroer, T.M., Raj, V.S., Zaki, A.M., Osterhaus, A.D.M.E., Haagmans, B.L., Gorbalenya, A.E., Snijder, E.J., et al. 2012. Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans. mBio 3, e00473\u201312.","journal-title":"mBio"},{"key":"1547_CR79","doi-asserted-by":"crossref","first-page":"eaba8399","DOI":"10.1126\/sciadv.aba8399","volume":"6","author":"N van Doremalen","year":"2020","unstructured":"van Doremalen, N., Haddock, E., Feldmann, F., Meade-White, K., Bushmaker, T., Fischer, R.J., Okumura, A., Hanley, P.W., Saturday, G., Edwards, N.J., et al. 2020. A single dose of ChAdOx1 MERS provides protective immunity in rhesus macaques. Sci. Adv. 6, eaba8399.","journal-title":"Sci. Adv."},{"key":"1547_CR80","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.biologicals.2021.04.005","volume":"71","author":"J Vandeputte","year":"2021","unstructured":"Vandeputte, J., Saville, M., Cavaleri, M., Friede, M., Hacker, A., Mueller, S.O., Rizzi, R., Smith, D., Thirstrup, S., Wagner, R., et al. 2021. IABS\/CEPI platform technology webinar: is it possible to reduce the vaccine development time? Biologicals. 71, 55\u201360.","journal-title":"Biologicals."},{"key":"1547_CR81","doi-asserted-by":"crossref","first-page":"8651","DOI":"10.1128\/JVI.00614-15","volume":"89","author":"A Volz","year":"2015","unstructured":"Volz, A., Kupke, A., Song, F., Jany, S., Fux, R., Shams-Eldin, H., Schmidt, J., Becker, C., Eickmann, M., Becker, S., et al. 2015. Protective efficacy of recombinant modified vaccinia virus Ankara delivering Middle East respiratory syndrome coronavirus spike glycoprotein. J. Virol. 89, 8651\u20138656.","journal-title":"J. Virol."},{"key":"1547_CR82","doi-asserted-by":"crossref","first-page":"11157","DOI":"10.1073\/pnas.1708727114","volume":"114","author":"AC Walls","year":"2017","unstructured":"Walls, A.C., Tortorici, M.A., Snijder, J., Xiong, X., Bosch, B.J., Rey, F.A., and Veesler, D. 2017. Tectonic conformational changes of a coronavirus spike glycoprotein promote membrane fusion. Proc. Natl. Acad. Sci. USA 114, 11157\u201311162.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1547_CR83","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.chom.2014.08.009","volume":"16","author":"Q Wang","year":"2014","unstructured":"Wang, Q., Qi, J., Yuan, Y., Xuan, Y., Han, P., Wan, Y., Ji, W., Li, Y., Wu, Y., Wang, J., et al. 2014. Bat origins of MERS-CoV supported by bat coronavirus HKU4 usage of human receptor CD26. Cell Host Microbe 16, 328\u2013337.","journal-title":"Cell Host Microbe"},{"key":"1547_CR84","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/cr.2013.92","volume":"23","author":"N Wang","year":"2013","unstructured":"Wang, N., Shi, X., Jiang, L., Zhang, S., Wang, D., Tong, P., Guo, D., Fu, L., Cui, Y., Liu, X., et al. 2013. Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4. Cell Res. 23, 986\u2013993.","journal-title":"Cell Res."},{"key":"1547_CR85","doi-asserted-by":"crossref","first-page":"e02040","DOI":"10.1128\/JVI.02040-16","volume":"91","author":"C Wirblich","year":"2017","unstructured":"Wirblich, C., Coleman, C.M., Kurup, D., Abraham, T.S., Bernbaum, J.G., Jahrling, P.B., Hensley, L.E., Johnson, R.F., Frieman, M.B., and Schnell, M.J. 2017. One-health: a safe, efficient, dual-use vaccine for humans and animals against Middle East respiratory syndrome coronavirus and rabies virus. J. Virol. 91, e02040\u201316.","journal-title":"J. Virol."},{"key":"1547_CR86","doi-asserted-by":"crossref","first-page":"5722","DOI":"10.1016\/j.vaccine.2014.08.028","volume":"32","author":"G Wong","year":"2014","unstructured":"Wong, G., Audet, J., Fernando, L., Fausther-Bovendo, H., Alimonti, J.B., Kobinger, G.P., and Qiu, X. 2014. Immunization with vesicular stomatitis virus vaccine expressing the Ebola glycoprotein provides sustained long-term protection in rodents. Vaccine 32, 5722\u20135729.","journal-title":"Vaccine"},{"key":"1547_CR87","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1080\/21645515.2017.1412024","volume":"14","author":"G Wong","year":"2018","unstructured":"Wong, G. and Qiu, X. 2018. Funding vaccines for emerging infectious diseases. Hum. Vaccin. Immunother. 14, 1760\u20131762.","journal-title":"Hum. Vaccin. Immunother."},{"key":"1547_CR88","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.3389\/fmicb.2019.01781","volume":"10","author":"CY Yong","year":"2019","unstructured":"Yong, C.Y., Ong, H.K., Yeap, S.K., Ho, K.L., and Tan, W.S. 2019. Recent advances in the vaccine development against Middle East respiratory syndrome-coronavirus. Front. Microbiol. 10, 1781.","journal-title":"Front. Microbiol."},{"key":"1547_CR89","doi-asserted-by":"crossref","first-page":"13133","DOI":"10.1038\/srep13133","volume":"5","author":"X Yu","year":"2015","unstructured":"Yu, X., Zhang, S., Jiang, L., Cui, Y., Li, D., Wang, D., Wang, N., Fu, L., Shi, X., Li, Z., et al. 2015. Structural basis for the neutralization of MERS-CoV by a human monoclonal antibody MERS-27. Sci. Rep. 5, 13133.","journal-title":"Sci. Rep."},{"key":"1547_CR90","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0140-6736(15)60454-8","volume":"386","author":"A Zumla","year":"2015","unstructured":"Zumla, A., Hui, D.S., and Perlman, S. 2015. Middle east respiratory syndrome. Lancet 386, 995\u20131007.","journal-title":"Lancet"}],"container-title":["Journal of Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12275-022-1547-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12275-022-1547-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12275-022-1547-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T17:51:39Z","timestamp":1735062699000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12275-022-1547-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,28]]},"references-count":90,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["1547"],"URL":"https:\/\/doi.org\/10.1007\/s12275-022-1547-8","relation":{},"ISSN":["1225-8873","1976-3794"],"issn-type":[{"value":"1225-8873","type":"print"},{"value":"1976-3794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,28]]},"assertion":[{"value":"20 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}